Transcytosable Peptide-Paclitaxel Prodrug Nanoparticle for Targeted Treatment of Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an extremely aggressive subtype associated with a poor prognosis. At present, the treatment for TNBC mainly relies on surgery and traditional chemotherapy. As a key component in the standard treatment of TNBC, paclitaxel (PTX) effectively inhibits the growth a...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Longkun, Zhao, Chunqian, Lu, Lu, Jiang, Honglei, Wang, Fengshan, Zhang, Xinke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10003159/
https://www.ncbi.nlm.nih.gov/pubmed/36902076
http://dx.doi.org/10.3390/ijms24054646

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10003159/
https://www.ncbi.nlm.nih.gov/pubmed/36902076
http://dx.doi.org/10.3390/ijms24054646

Ejemplares similares